- Advertise
- About OncLive
- Editorial Board
- MJH Life Sciences brands
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2025 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Latest Conference Articles
The OncLive® Conference page includes a listing of all conferences covered by OncLive®, including the ASCO, ESMO, SITC, EHA, ASH, and SABCS annual meetings, as well as the Chemotherapy Foundation Symposium and Miami Breast Cancer Conference, among many others. Conference coverage incorporates articles and interviews in written and video format.
Dr Peters on the Importance of Consensus Meetings to Address Clinical Ambiguity in Lung Cancer
October 16th 2025, 3:16pm
Bridging the Gaps in Lung Cancer
Solange Peters, MD, PhD, discusses the necessity of global consensus meetings to navigate clinical "gray zones" in lung cancer management.
Dr Passaro on the Role of MET in Guiding Treatment Strategies After EGFR TKI Progression in NSCLC
October 16th 2025, 12:51am
Bridging the Gaps in Lung Cancer
Antonio Passaro, MD, PhD, discusses testing methodologies and clinical trials for MET, the most studied resistance biomarker, following progression on EGFR TKIs.
Dr Faivre-Finn on Areas of Debate Surrounding Concurrent Chemoradiotherapy Plus IO in LS-SCLC
October 15th 2025, 11:54pm
Bridging the Gaps in Lung Cancer
Corinne Faivre-Finn, MD, discusses ongoing clinical debates regarding patient selection and optimal delivery of concurrent chemoradiotherapy followed by immunotherapy in LS-SCLC.
Countdown to ESMO 2025: Catch Up on OncLive’s Extensive Tumor-Specific Previews
October 13th 2025, 6:00pm
Preview the top lung, breast, GI, GU, gynecologic, and hematologic oncology abstracts and topics ahead of the 2025 ESMO Congress.
OncLive Poll Results Reveal Most Anticipated GI Cancer Abstracts and Subtypes Ahead of ESMO 2025
October 10th 2025, 1:00pm
See poll results highlighting the top gastrointestinal oncology abstracts and subtypes to watch at the 2025 ESMO Congress.
Poll Results Highlight Gynecologic Oncology Abstracts to Watch Ahead of ESMO 2025
October 10th 2025, 12:00pm
ESMO Congress: Gynecologic Cancers
See poll results highlighting the top gynecologic oncology abstracts and subtypes to watch at the 2025 ESMO Congress.
ESMO 2025 Will See Novel Agents Emerge and Standard Strategies Shift in GI Oncology
October 9th 2025, 2:00pm
Ahead of the 2025 ESMO Congress, GI cancer experts share the gastric cancer and CRC research they’re most looking forward to seeing at the meeting.
Inside the Most Anticipated Genitourinary Cancer Abstracts: What to Watch at ESMO 2025
October 8th 2025, 5:33pm
Experts in genitourinary oncology share key insights on the most anticipated data and abstracts expected to shape discussions at the 2025 ESMO Congress.
Poll: Vote on the Top Gynecologic and GI Cancer Abstracts/Topics to Watch at ESMO 2025
October 6th 2025, 6:00pm
Vote on the top abstracts and topics to watch in gynecologic and gastrointestinal oncology during the 2025 ESMO Congress.
OncLive Polls Highlight Top Votes on Anticipated Breast Cancer Abstracts at ESMO 2025
October 3rd 2025, 6:00pm
Breast cancer experts vote on their most anticipated abstracts on social media ahead of the 2025 ESMO Congress.
Experts Reflect on Ideas From MiBA 2025 That Will Propel the Future of AI-Driven Oncology
October 2nd 2025, 7:00pm
Oncology experts and AI advocates discuss insights about how AI can help manage tasks, keep up with evolving treatment practices, and improve patient care.
Inside the Most Anticipated Lung Cancer Abstracts: What to Expect From ESMO 2025
October 2nd 2025, 1:00pm
Ahead of the 2025 ESMO Congress, OncLive spoke with experts in lung cancer care to preview the most anticipated meeting abstracts.
How AI-Driven Platforms Can Transform Clinical Trial Efficiency in Cancer Care
October 1st 2025, 1:00pm
Katie Goodman, RN, BSN, discusses the ways in which artificial intelligence can help speed up the pace of clinical trial accrual
Advances in Targeted Therapies and ADCs in Gynecologic Cancer Are Highly Anticipated at the 2025 ESMO Congress
October 1st 2025, 12:00pm
ESMO Congress: Gynecologic Cancers
Experts in the gynecologic cancer landscape highlight their most anticipated presentations ahead of the 2025 ESMO Congress.
Dr Shields on the Evolving Role of Prophylactic Cranial Irradiation in SCLC
September 30th 2025, 2:58pm
PER® Winter Lung Cancer Conference
Misty D. Shields, MD, PhD, discusses the modern role for prophylactic cranial irradiation in extensive-stage SCLC management.
Hematologic Oncology Abstracts to Watch at the 2025 ESMO Congress
September 30th 2025, 1:00pm
ESMO Congress: Hematologic Malignancies
A preview of the hematologic oncology abstracts and presentations to watch at the 2025 ESMO Congress in Berlin.
AI Offers Multitude of Benefits in Community Practice, But Barriers to Implementation Remain
September 29th 2025, 7:55pm
Kashyap Patel MD, ABIM, BCMAS, discusses the present challenges with integrating AI tools into community practice.
Poll: Vote on the Top Breast Cancer, Hematology Abstracts to Watch at ESMO 2025
September 29th 2025, 5:00pm
AI-Based Tools Offer Clinical Decision-Making Support in Community Practice
September 29th 2025, 12:25pm
Jim Chen, MD, discusses how artificial intelligence can aid community oncologists in providing optimal care.
Dr Birhiray on Advancing Clinical Trials in Oncology Using AI Tools and Tactics
September 29th 2025, 12:40am
Ruemu E. Birhiray, MD, discussed the advantages of using AI-based tools to enhance community-based clinical trials in oncology.